Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
DC Funds, LP (CIK 1869028) reported $1.5M across 3 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: TCRX ($630,000, 42.40%), HOWL ($490,486, 33.01%), BRNS ($365,414, 24.59%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | TCRX | TSCAN THERAPEUTICS INC | $630,000 | 42.40% | 630,000 | Hold |
| 2 | HOWL | WEREWOLF THERAPEUTICS INC | $490,486 | 33.01% | 589,102 | Hold |
| 3 | BRNS | BARINTHUS BIOTHERAPEUTICS PL | $365,414 | 24.59% | 642,204 | Hold |
Source: SEC Form 13F filings · as of 2026-03-31